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ABSTRACT 
In the real world, most objects and data have multiple types of 
attributes and inter-connections. Such data structures are named 
“Heterogeneous Information Networks” (HIN) and have been 
widely researched. 
 Biological systems are also considered to be highly 
complicated HIN. In this work, we review various applications of 
HIN methods to biological and chemical data, discuss some 
advanced topics, and describe some future research directions. 
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• Applied computing → Life and medical sciences → 
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KEYWORDS 
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1 INTRODUCTION 
 The smallest unit of life is a cell. Inside the cell membrane, based 
on the concept of central dogma [1], information from DNA is 
transcripted to RNA and successively translated to proteins (Fig. 
1). In recent years, non-coding RNA and chemical modifications 
of histone proteins and DNA sequences have also been identified 
as an exception to the traditional concept [2]. Beyond cell exterior, 
many signals such as pathogen infection, experimental 
perturbation, drug ingestion, and lifestyle interfere with biological 
systems. Such changes in the ambient cellular environment affect 
the biological systems both quantitatively (e.g., change in the 
amount of RNA) and qualitatively (e.g., change in the base 
sequence of DNA), finally causing a change in phenotypes such 
as disease, morphology and physiological properties. 
Although there is no comprehensive experimental method for 
measuring all systems at once, “omics” research [3] has been 
tackling the exhaustive measurement of systems by limiting a 
single type of biomolecule. For example, genome (gene + ome) 
studies or genomics, focus on only DNA sequences, and 
transcriptome (transcript + ome) studies, or transcriptomics, focus 
only on RNA   sequences, and so on (Fig. 1). Such studies are 
becoming possible because of the rapid development of 
experimental equipment such as microarray, massively parallel 
DNA sequencing technology, and mass-spectrometry [3]. Omics 
studies are often performed to determine the association of two or 
three data domains and can be expressed in ER (Entity-
Relationship) diagram (Fig. 2, left). For example, the study of 
DEG (Differentially Expressed Genes) [4] focuses on the 
association between gene expression-phenotypes; such research 
investigates what genes and phenotypes are linked at an instance-
level (Fig. 2, right). Likewise, GWAS (Genome-wide Association 
Study) [5] focuses on the association between SNP (Single 
Nucleotide Polymorphism)-phenotype and so on [3-33]. The 
abbreviations of other omics studies are summarized in Appendix. 
Although many analytical methods have been proposed for 
each biological data type, such methods have been highly domain-
specific, and cross-domain studies (e.g., multi-omics) have still 
not been straightforward. Recently, “Heterogeneous Information 
Networks” (HIN) [34,35] data structures and the analytical 
methods have been applied to some biological problems and can 
form a unified framework for handling such complicated and 
inter-connected data. In this work, we review the various 
applications of HIN-based methods to biological and chemical 
data, discuss some advanced topics, and describe some future 
research directions.  
The remaining sections are organized as follows. Section 2 
describes the definition of graph that is used in this paper. Section 
3 presents the HIN-based methodology used in previous papers. 
Section 4 describes the effectiveness of HIN for biological data.  
Section 5 introduces the concept of “Guilt-by-Association”, which 
is important for analyzing biological data. Section 6 introduces 
previous applications of HIN-based methods. Section 7 describes 
some future research directions. Finally, Section 8 concludes this 
paper. 
2 DEFINITIONS 
In this section, we define the data structure described in this work. 
DEFINITION 1: Homogeneous Information 
Network 
Consider a single entity in the ER diagram in Fig. 2 such as gene 
regulation network (GRN) [16]. Such a system can be defined as 
an undirected graph G = (V, E), where V represents the set of 
nodes, and E is the set of edges on the graph.  Because of the 
types of nodes |V| = 1 and the types of edges |V| = 1, such data 
structure is defined as a homogeneous information network. The 
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graph can also be defined as a symmetric adjacency matrix (Fig. 
2, right), where the number of rows and columns are both the 
number of instances of the gene expression and each element has 
1 (linked) or 0 (not linked). 
DEFINITION 2: Heterogeneous Information 
Network 
When the types of nodes or types of edges are larger than 1, the 
graph is defined as a “Heterogeneous Information Network” 
(HIN). For example, consider multiple entities connected to each 
other on the ER diagram in Fig. 2, such as DEG [4]. Although 
such systems are also defined as G’ = (V’, E’), where V’ 
represents the set of nodes, E’ represents the set of edges of the 
graph, |V’| = 2 and this graph is HIN. Such a relationship can also 
be defined as an asymmetric adjacency matrix in a similar manner 
of a homogeneous network (Fig. 2, right). 
In this work, we introduce some HIN-based methods, while 
considering the difference of nodes. Although there are some 
methods for considering the difference of edge types, such data 
structures can form a higher-order matrix (tensor), which is a 
more advanced topic [36]. Therefore, we will focus on only the 
differences among node types. 
3 METHODS USED FOR BIOLOGICAL HIN 
In this section, we introduce the methods used on biological data 
defined as HIN. Although a comprehensive review of the 
algorithms is beyond the scope of this work, we will introduce 
some methods that are widely used on biological and chemical 
data. Most of the time, HIN-based methods are used for link 
prediction problems for biological HIN. After constructing the 
HIN by experimental data or external databases, many similarities 
between two nodes have been applied to decide which nodes are 
similar to each other on HIN.  
Many similarity scores of graph theory and complex 
networks are applied to HIN data to capture local or global 
network topology, such as direct neighborhood, shortest path 
length, diffusion Kernel [37], Katz measure [38-41], the number 
of paths (PathCount), and the transition matrix of random walk 
(RW) [42]. 
According to previous studies, the methods which have 
some parameters controlling local/global proximity and model the 
differences among node types, seem superior to the simple 
measures describe above. For example, Random Walk with 
Restart on HIN (RWRH) is widely used for biological HIN [43-
49]. RWRH uses the multiple domain data, constructs HIN, 
defines the transition probability within-domain and cross-domain 
using experimental data or external databases, performs an 
iterative random walk calculation, and finally outputs the  
similarity among nodes. Bi-directional RWR [50,51], which is an 
extension of the RWRH, is also used. 
Furthermore, some meta-path based methods have also 
been applied to biological HIN [42,52-57]. Such approaches 
explicitly define the different semantic paths. For example, in Fig. 
2, multiple paths between Gene Expression and Phenotype, with 
the limitation of a path length of 2, can be considered, such as 
Gene Expression–Chemical–Phenotype path, Gene Expression–
Microbe–Phenotype path, and so on. Once the similarities of all 
paths are calculated, any analytical methods are applicable [42,57]. 
Though PathSim [58] is perhaps the best-known similarity used in 
meta-path based methods, HeteSim [59] is practically used for 
biological HIN because HeteSim can be applied to symmetric 
paths. The methodologies are still developing, such as the 
appropriate path length [60], informative meta-path selection [61] 
and weighted summation of each path [62]. 
Figure 1: Biological Systems and corresponding omics 
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Some HIN, such as biomedical RDF data, has several 
tens of domains that are highly complicated. In such cases, 
possible combinations of transition matrices (RWRH) or different 
semantic paths (HeteSim) are exponentially increased and data 
preparation tasks become very time-consuming and laborious. For 
simplification of such tasks, some homogeneous information 
network-based methods, which do not recognize the differences 
among node types, are directly applied to HIN, such as network 
embedding methods (https://github.com/chihming/awesome-
network-embedding) [63-65]. 
4 WHY IS HIN USEFUL FOR BIOLOGICAL 
DATA? 
The effectiveness of HIN-based methods is featured in some 
biological research fields. There may be two reasons for that. 
Firstly, HIN-based methods enhance the S/N ratio of 
previous biological data analysis. For example, here, we consider 
the prediction problem of gene-disease relationships (Fig. 3, upper 
row). 
Although such relationships are measured experimentally by DEG 
[4] or GWAS [5] study, such data are very noisy and contains 
many false positives. HIN-based methods can be used not only to 
measure data but also incorporating previous knowledge about 
genes/diseases and can seamlessly integrate them. Such data 
integration will elevate the true link to a higher rank 
(“prioritization”) and can also detect hidden candidate links 
(“missing-link”). 
Secondly, HIN-based methods can connect different 
biological domain data. Again, consider the prediction problem of 
drug-protein relationships and suppose that there are two data 
matrices describing drug side-effect relationships and side-effect 
protein relationships (Fig. 3, lower row). HIN-based methods 
indirectly connect drug-protein relationship via internal side effect 
entity, even if the drug-protein relationships are not measured 
simultaneously. 
5 GUILT-BY-ASSOCIATION 
In this section, we explain the principle of “Guilt-by-Association” 
(GBA) [66]. When we applied HIN-based methods to biological 
data, we will implicitly accept this principle. GBA indicates that 
biomolecules that are associated or interacting are more likely to 
share functions. For example, in the case of gene-disease 
prediction problems, GBA assumes that an unknown gene and a 
well-known gene are similar and a well-known gene is related to a 
disease, the unknown gene is also related to the disease (Fig. 4).  
Figure 2: ER-Diagram of previous omics studies 
Figure 4: Concept of Guilt-By-Association 
Figure 3: Effectiveness of HIN-based methods against 
biological data 
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Integrated pieces of prior knowledge will become a by-pass of 
information and connect indirect links on HIN that have still not 
been found. Although this is heuristics rather than rigorous rules, 
such as a mathematical theorem, many studies suggest the 
effectiveness as describe below.  
6 CASE STUDIES OF HIN APPLICATIONS 
TO BIOLOGICAL DATA 
In this section, we describe some previous applications of HIN-
based methodology to biological data. 
6.1 Drug repurposing 
The process of finding new drugs is very time-consuming and 
costs a large amount of money. Drug repurposing (or 
repositioning) [20] is the application of known drugs to new 
diseases and is considered a way to resolve this problem; such 
drugs have already passed a number of toxicity and other tests, 
omitting significant costs and time to bring a drug to market. 
Though searching across space for possible combinations of 
known drugs and diseases is extremely challenging, “in silico” 
(computational) approaches have been used to list the candidate 
drug-disease pairs. 
To find the missing link, an HIN schema, which is the first 
example in Fig. 3, has often been constructed. Three types of 
adjacency matrices have been prepared: 1. a drug–drug adjacency 
matrix, which is constructed based on the similarity among the 
chemical structures of drugs, the similarity of the related side 
effects and the semantic similarity of disease ontology; 2. a drug-
target adjacency matrix, which is constructed using a prior 
knowledge database; and 3. a target-target adjacency matrix, 
which is constructed, using a prior knowledge database of protein-
protein interactions (PPI), with sequence similarity as amino acids 
and semantic similarity of disease-related ontology. Finally, Katz 
[38] and RWRH [43,44] have been widely applied to find the 
missing link on the HIN. 
More complicated HIN schemas have also been tried. Gang 
Fu et. al.  [52] constructed HIN using 12 types of biological data, 
calculated 51 paths, implemented a simple random walk measure 
on each path and evaluated which path is effective in predicting 
previous drug–target relationships. Congcong Li et. al. [53], used 
HeteSim [59] against HIN and compared it with previous method 
based on homogeneous information networks. Other methods for 
drug–target prediction are reviewed in [67]. 
6.2 Identification of Gene-Phenotype 
Relationships  
Understanding gene function is fundamental to biology, but 
exhaustive investigation of the function is still difficult. Some 
systematic approaches have been introduced, such as DEG [4] or 
GWAS [5] study (Fig. 2). In such approaches, thousands to 
millions of biomolecules have been investigated simultaneously, 
with a slight association between a change in quality or quantity 
of biomolecules and phenotypes. Such experimental designs are 
intrinsically influenced by experimental noise, resulting in the 
analysis containing many false positive. To avoid the noise and 
prioritize the true positives, many HIN-based methods have been 
developed. 
As in 6.1, an HIN schema, which is the first example of Fig. 
3, is often constructed. Three type of adjacency matrices are 
prepared; 1. a gene-gene adjacency matrix, which is constructed 
using prior knowledge, a PPI database, semantic similarity of 
gene ontology (GO), similarity of gene expression measured by 
omics experiments, sequence similarity of amino acids and 
similarity of related pathways; 2. a gene-disease adjacency matrix, 
which is constructed using previous knowledge; and 3. a disease-
disease adjacency matrix, which is constructed using a semantic 
similarity of disease related ontology. Finally, Katz [39], RWRH 
[45,46] and Bi-directional RWR [50] are widely applied. 
As more complicated HIN schemas, Xiangxiang Zeng [54] 
integrated the gene-phenotype relationship of multiple species as 
HIN, generated a meta-path between gene-human phenotypes and 
applied HeteSim. Other methods for gene-disease prediction are 
reviewed in [37]. 
6.3 Functional annotation of non-coding RNA 
Non-coding RNA is a generic name for RNAs that are not 
translated to proteins [15]. Based on its sequence length, cellular 
location and physical properties, many types of non-coding RNA 
are categorized. Although such RNAs have been regarded as 
“junk”, recent international genomic projects, such as ENCODE 
[68] and Epigenome RoadMap [69], have suggested that many 
non-coding RNAs are functional and the functional annotation is 
becoming an important problem. In particular, HIN-based 
methods are applied to miRNA and lncRNA as shown below. 
miRNA (micro RNA) is one class of small non-coding 
RNA that is less than 22 nucleotides. The miRNA-protein 
complex, which consists of miRNA and its partner proteins, 
interacts with target mRNA and interferes with the translation 
(RNA interference or RNAi, Fig. 1). Because only a few target 
gene sets of human miRNAs have an intersection, functional 
annotation of miRNA is still a difficult task. 
lncRNA (long noncoding RNA) is a class of non-coding 
RNA that is longer than 200 nucleotides. Some large-scale 
genomic projects, such as GENCODE [70], detect the expression 
of some lncRNAs in some tissues and imply a relationship with 
the tissue-specific functions. However, except for some well-
known lncRNA, such as XIST and HOTAIR, most of the lncRNA 
functions remain unknown. 
To leverage such weak non-coding RNA – phenotype 
(especially disease) links, HIN-based methods, such as Katz [40], 
RWRH [47,48], HeteSim [55,56] and the meta-path-based logistic 
regression model [57], have been applied. 
6.4 Human Microbe – Disease Association 
rRNA (ribosomal RNA) is part of a ribosome, which is a protein-
RNA complex that is widely used for investigation of the 
phylogenic relationship among organisms. In particular, 16S 
rRNA, which is a prokaryote-specific molecule, is used for 
bacteria research [71]. The relationships between the existence of 
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specific bacterial 16S rRNA and the host human disease have 
been investigated by the Human Microbe-Disease Association 
Database (HMDAD) [72], and HIN-based methods have been 
applied to the data [41,49,51]. 
7 ADVANCED TOPICS 
In this section, we introduce some advanced topics for future 
biological data analysis with HIN. Owing to the outstanding 
property of HIN-based methods described above, many biological 
problems can be solved. 
7.1 Biological Domain Specific Topics 
Generally, biological data are noisy, and sometimes the value is 
systematically lost. Therefore, missing-value estimation methods 
(imputation) have been developed in each biological domain. 
HIN-based methods may work for imputation problems; 
imputation is theoretically similar to collaborative filtering [73], 
which is known as the methodology used in item-recommendation 
systems, such as Amazon and Netflix and HIN-based methods, 
are still applied to collaborative filtering problems [74]. 
 When using omics data, a large number of biomolecules are 
simultaneously measured. Generally, the number of biomolecules 
related to phenotypes is considered small, and hypothetical tests 
are applied and significant molecules are listed. Some 
hypothetical tests on HIN have been prepared such as the 
hypergeometric test [48], Wilcoxon rank-sum/Kruskal-Wallis test 
[75] and Permutation test [76]. 
Furthermore, it is natural to think that the relationships 
among different biological data are many-to-many, rather than 1-
to-1. Such relationships can be detected by a latent variable model 
such as matrix factorization methods [77]. Actually, the restricted 
Boltzmann machine, which is one of the latent variable models, 
successfully detects multi-lncRNA-multi-diseases relationships 
[78]. 
In the biological research community, many end-users of 
these analytical methods are not programmers but experimental 
researchers. Therefore, these methods should be implemented in a 
format that users can easily try on their own data. In addition to 
the release from the GitHub repository, implementation in a 
Bioconductor (R) package is desirable; many omics analytical 
methods are implemented and an analytical pipeline is 
implemented in combination with multiple R packages (e.g., 
https://bioconductor.org/help/workflows/). Some HIN-based 
methods are still implemented as R packages [79,80]. 
7.2 More Specific, Noisy and Sparse Data 
Although previous applications of HIN-based methods to 
biological data have focused on an entity such as drugs and genes 
(see Section 6), these methods are also effective against more 
specific data because the link between such data and previous 
knowledge is considered to be weak due to the small number of 
studies. For example, studies have used data from some non-
coding RNA such as circRNA and eRNA, long range interaction 
of SNP-gene expression (trans-eQTL) [81], phosphorylation [82], 
non-model organisms and cross-species analysis [83], orphan and 
rare disease [67], traditional medicine [84], and so on. 
Some biological data, such as epigenomic data (Fig. 1) 
[2,25,27,28] and brain MRI images [85], are highly noisy and 
sparse. Because such data have low S/N ratios, the HIN-based 
method may work for such data. 
7.3 Higher Resolution Data 
The technological innovation of a high-resolution measurement of 
a biological system is rapidly progressing. For example, previous 
experiments by disease researchers were designed to make 
comparisons between patients’ groups and control groups, but 
recent personalized medicine [86] focuses on each patients’ 
heterogeneity. In the same way, a single-type omics will become 
multi-omics resolution [3,10], gene expression measurement of 
both alleles will become allele specific expression [87], a single 
gene-level analysis will become isoform-resolution [88], and a 
microbe analysis based on 16S rRNA will become a Dual RNA-
Seq [11], which can focus on the gene expression of pathogen and 
host cells simultaneously. 
7.4 Single-Cell Omics and Human Cell Atlas 
Typical omics experiments have been applied to samples 
consisting of thousands or millions of cells. The recent rapid 
development of DNA sequence technologies and cell capture 
technologies enable us to perform experiments at a single-cell 
level (single-cell omics [89]) such as single-cell genome, 
transcriptome, epigenome, proteome, metabolome, single-cell 
multi-omics [90] and single-cell dual RNA-Seq [91]. These 
ultimately high-resolution experiments identify novel cell types 
consisting of tissues [92], changes in gene expression along with 
cell development [93] and spatial expression patterns [94]. In spite 
of some success, single-cell data are very noisy and sparse, due to 
the small number of biomolecules within single-cell. The HIN-
based method will enhance the S/N ratio of links between each 
molecules and cell types and will integrate different types of 
omics data. 
The human cell atlas (https://www.humancellatlas.org), 
which is funded by the Chan Zuckerberg Initiative 
(https://chanzuckerberg.com), was started in 2016 [95]. The atlas 
will perform single-cell RNA-Seq against 30 million to 10 million 
cells, categorize cell types from the human body, and investigate 
some mechanisms of disease at the single-cell level. The atlas data 
will become a reference for interpretation of further generating 
other types of single-cell omics data. HIN-based methods will 
seamlessly integrate these different domain data, such as single-
cell Epigenome-single-cell RNA-Seq-Gene Function path, and 
will support interpretation of the causal relationships among them, 
within common cellular space. 
7.5 More Complicated Data Structure 
Many HIN-based methods are based on an adjacency matrix, 
which means that each element has 1 (linked) or 0 (not linked). 
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However, some biological relationships have a plus direction (e.g., 
up-regulated genes) and minus direction (e.g., down-regulated 
genes). Such signed graph relationships are defined as three 
values (-1: negative, 0: not linked, and 1: plus). Furthermore, 
some data are generated from spatiotemporally different sample 
points. Because such data structures are defined as multiple 
matrices or tensor, tensor-based methods are needed [36]. 
More sophisticated algorithms, such as graph convolutional 
neural network [96], which is the graph extension of the deep 
learning method or metapath2vec [97], which is a combination of 
meta-paths and network embedding methods, may work for a 
graph with a complicated network schema. 
7.6 More General Framework and Community-
Driven Knowledge Sharing 
Some HIN-based software, such as SLAP [98], Hetionet [60], 
Medusa [77], and DeepWalk implemented at Biohackathon 2016 
[64], integrate a large variety of domain data. In principle, any 
connection between start-node to end-node can be linked in any 
combination. Therefore, more general and unified frameworks 
may be able to be implemented, wherein related data are assigned 
to query data without a consideration of different data domains, at 
single search interface (Fig. 5).  
There are still some problems to address. Firstly, the best 
practices of data analysis workflow in each data domain are not 
always determined. Therefore, the data generated by different 
laboratories may not be directly comparable, if the software used 
is different. Therefore, to standardize the analytical results of data 
from a primary database, secondary databases for re-analyzing the 
data and providing them are essential. 
Secondly, the vocabulary of biology is not always unique. For 
example, POU5F1, which is a famous gene for establishing the 
iPS cell, has some synonyms, such as MGC22487, Oct3, and Oct4 
(https://www.genenames.org/cgi-
bin/gene_symbol_report?hgnc_id=HGNC:9221). Therefore, to 
integrate the different laboratory and different domains, the 
designation of common ontology is needed. 
As we described above, there are wide variety of biomolecules 
and data domains, the biological databases assigned different 
biomolecular types to different types of IDs such as Gene ID and 
Protein ID. For such a reason, ID conversion across different 
biological domains is laborious task. In view of this situation, 
some biological specific programming framework such as BioPerl, 
BioPython, BioRuby and BioJulia provided ID conversion 
functions via Web-API. To the contrary, Bioconductor provided 
the corresponding ID tables as R packages. Recently, semantic 
web technologies have been applied to biological databases. Some 
databases are already reconstructed in RDF format and the data 
can be seamlessly searched without consideration of difference of 
data domains [64]. However, the query language of Semantic 
Web (SPARQL) can only retrieve corresponding data and 
SPARQL cannot perform prioritization or missing-link prediction, 
which is described in this work. Therefore, combined use of 
SPARQL and HIN-based methods will be considered, along with 
the differences in user purpose. 
8 CONCLUSIONS 
In this work, we introduced some applications of HIN-based 
methods to biological data and described some future research 
directions. Many biological data analyses are predictions of 
associations between two entities, and the outstanding property of 
HIN-based methods will be preferable for noisy, sparse, and 
complicated biological data and leverage some unresolved 
biological problems. 
Figure 5: Future Biological Data Analysis 
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Appendix: Abbreviation List 
circRNA: Circular Ribonucleic Acid 
CNV: Copy Number Variation 
DEG: Differentially Expressed Gene 
DNA: Deoxyribonucleic Acid 
eQTL: Expression Quantitative Trait Loci 
eQTM: Expression Quantitative Trait Methylation 
eRNA: Enhancer Ribonucleic Acid 
EWAS: Epigenome-wide Association Study 
GBA: Guilt-By-Association 
GRN: Gene Regulatory Network 
GSEA: Gene Set Enrichment Analysis 
GWAS: Genome-wide Association Study 
LD: Linkage Disequilibrium 
lncRNA: Long non-coding Ribonucleic Acid 
LOH: Loss of Heterozygosity 
MeSH-ORA: Medical Subject Headings - Over-representation 
Analysis 
miRNA: Micro Ribonucleic Acid 
mQTL: Metabolomic Quantitative Trait Loci or Methyl 
Quantitative Trait Loci 
MWAS: Metabolome-wide Association Study or Microbe-wide 
Association Study 
ORA: Over-representation Analysis 
PheWAS: Phenome-wide Association Study 
PPI: Protein-Protein Interaction 
pQTL: Protein Quantitative Trait Loci 
QSAR: Quantitative Structure Activity 
QTL: Quantitative Trait Loci 
RDF: Resource Description Framework 
RNA: Ribonucleic Acid 
rRNA: Ribosomal Ribonucleic Acid 
SNP: Single Nucleotide Polymorphism 
TF: Transcriptional Factor 
TWAS: Transcriptome-wide Association Study 
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